Wells Fargo’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-289
| Closed | -$4.32K | – | 7927 |
|
|
2022
Q4 | $4.32K | Buy |
289
+105
| +57% | +$1.45K | ﹤0.01% | 5816 |
|
|
2022
Q3 | $2K | Sell |
184
-279
| -60% | -$2.14K | ﹤0.01% | 6246 |
|
|
2022
Q2 | $3K | Sell |
463
-1,483
| -76% | -$7.18K | ﹤0.01% | 6272 |
|
|
2022
Q1 | $10K | Sell |
1,946
-405
| -17% | -$1.67K | ﹤0.01% | 6290 |
|
|
2021
Q4 | $11K | Buy |
2,351
+1
| +0% | +$6 | ﹤0.01% | 6519 |
|
|
2021
Q3 | $14K | Sell |
2,350
-1
| -0% | -$6 | ﹤0.01% | 6109 |
|
|
2021
Q2 | $15K | Sell |
2,351
-6,517
| -73% | -$44.9K | ﹤0.01% | 6025 |
|
|
2021
Q1 | $65K | Sell |
8,868
-31,232
| -78% | -$269K | ﹤0.01% | 5692 |
|
|
2020
Q4 | $231K | Sell |
40,100
-12,717
| -24% | -$72.8K | ﹤0.01% | 5007 |
|
|
2020
Q3 | $313K | Buy |
52,817
+21,604
| +69% | +$107K | ﹤0.01% | 4685 |
|
|
2020
Q2 | $161K | Buy |
31,213
+5,557
| +22% | +$35.1K | ﹤0.01% | 5019 |
|
|
2020
Q1 | $93K | Buy |
25,656
+5,961
| +30% | +$29.6K | ﹤0.01% | 5101 |
|
|
2019
Q4 | $123K | Sell |
19,695
-4,206
| -18% | -$31K | ﹤0.01% | 5205 |
|
|
2019
Q3 | $202K | Buy |
23,901
+5,929
| +33% | +$44.1K | ﹤0.01% | 4960 |
|
|
2019
Q2 | $121K | Sell |
17,972
-8,364
| -32% | -$71.6K | ﹤0.01% | 5227 |
|
|
2019
Q1 | $216K | Buy |
26,336
+1,094
| +4% | +$11.3K | ﹤0.01% | 4789 |
|
|
2018
Q4 | $404K | Buy |
25,242
+5,728
| +29% | +$126K | ﹤0.01% | 4469 |
|
|
2018
Q3 | $646K | Buy |
19,514
+7,067
| +57% | +$182K | ﹤0.01% | 4263 |
|
|
2018
Q2 | $281K | Buy |
12,447
+1,058
| +9% | +$25.1K | ﹤0.01% | 4849 |
|
|
2018
Q1 | $330K | Buy |
11,389
+725
| +7% | +$21.2K | ﹤0.01% | 4681 |
|
|
2017
Q4 | $298K | Buy |
+10,664
| New | +$331K | ﹤0.01% | 4756 |
|
|
2017
Q1 | – | Sell |
-80
| Closed | – | – | 6633 |
|
|
2016
Q4 | $0 | Hold |
80
| – | – | ﹤0.01% | 6561 |
|
|
2016
Q3 | $1K | Hold |
80
| – | – | ﹤0.01% | 6144 |
|
|
2016
Q2 | $1K | Hold |
80
| – | – | ﹤0.01% | 6044 |
|
|
2016
Q1 | $1K | Hold |
80
| – | – | ﹤0.01% | 6128 |
|
|
2015
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 6140 |
|
|
2015
Q3 | $1K | Hold |
80
| – | – | ﹤0.01% | 6111 |
|
|
2015
Q2 | $1K | Hold |
80
| – | – | ﹤0.01% | 6278 |
|
|
2015
Q1 | $1K | Hold |
80
| – | – | ﹤0.01% | 6095 |
|
|
2014
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 6130 |
|
|
2014
Q3 | $1K | Hold |
80
| – | – | ﹤0.01% | 6117 |
|
|
2014
Q2 | $1K | Hold |
80
| – | – | ﹤0.01% | 6044 |
|
|
2014
Q1 | $1K | Hold |
80
| – | – | ﹤0.01% | 5802 |
|
|
2013
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 5653 |
|
|
2013
Q3 | $2K | Hold |
80
| – | – | ﹤0.01% | 5467 |
|
|
2013
Q2 | $2K | Buy |
+80
| New | +$3.42K | ﹤0.01% | 5401 |
|
Wells Fargo's AVEO Position: Q1 2023 in Review
Wells Fargo sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 289 shares — an estimated $4.32K sold.
Wells Fargo first reported a position in AVEO in Q2 2013 and held it in 36 quarters. The position peaked at $646K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Wells Fargo reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Wells Fargo sold 289 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $4.32K.
- Wells Fargo first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 36 quarters.
- Wells Fargo's AVEO Pharmaceuticals, Inc. position peaked at $646K in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.